Elodie Degout-Charmette

This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Biomerieux, Inc., Bioaster. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elodie Degout-Charmette. Retrieved from https://idiyas.com/inventor/elodie-degout-charmette

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Toussieux, FR (2016 - 2018)
Tossieux, FR (2018)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12511919 - Method for classifying a sequence of input images representing a particle in a sample over time (2025-12-30),

2. 9874570 - Method of detecting at least one mechanism of resistance to cephalosporins by mass spectrometry (2018-01-23),

3. 9874568 - Method of detecting at least one mechanism of resistance to carbapenems by mass spectrometry (2018-01-23),

4. 9551020 - Method of detecting at least one mechanism of resistance to carbapenems by mass spectrometry (2017-01-24),

5. 9506932 - Method of detecting at least one mechanism of resistance to cephalosporins by mass spectrometry (2016-11-29),

Title: Elodie Degout-Charmette: Innovator in Antimicrobial Resistance Detection

Introduction

Elodie Degout-Charmette is a prominent inventor based in Toussieux, France. She has made significant contributions to the field of antimicrobial resistance detection, holding a total of four patents. Her work focuses on innovative methods that enhance the detection of resistance mechanisms in microorganisms.

Latest Patents

One of her latest patents is a method of detecting at least one mechanism of resistance to carbapenems by mass spectrometry. This invention pertains to a method that identifies markers of resistance in microorganisms contained in a sample, specifically targeting carbapenem antibiotics. The resistance markers identified are proteins or peptides derived from the microorganisms. Another notable patent involves a method of detecting mechanisms of resistance to cephalosporins, also utilizing mass spectrometry. Similar to her carbapenem patent, this invention focuses on identifying resistance markers that are proteins or peptides from the microorganisms.

Career Highlights

Elodie has worked with notable companies in the biotechnology sector, including bioMérieux, Inc. and Bioaster. Her experience in these organizations has allowed her to develop and refine her innovative methods for detecting antimicrobial resistance.

Collaborations

Throughout her career, Elodie has collaborated with esteemed colleagues such as Yannick Charretier and Jean-Philippe Charrier. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Elodie Degout-Charmette is a trailblazer in the field of antimicrobial resistance detection, with a strong portfolio of patents that reflect her innovative spirit. Her contributions are vital in the ongoing battle against antibiotic resistance, showcasing the importance of research and development in healthcare.

Profile summary based on public USPTO records.